Nanoparticulate System Based on Calcium-Crosslinked Carbomer Retards Percutaneous Drug Permeation: New Insight Into Skin Barrier Functions
- 13 October 2022
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (12) , 3331-3343
Abstract
Background The stratum corneum poses a formidable barrier for dermal and transdermal delivery of drugs. Besides the stratum corneum barrier, the viable epidermis poses another challenge to pharmaceutical formulators. A drug is probably transdermally permeable if it rapidly crosses the epidermal secondary barrier, while stimulation of lamellar body secretion from granular cells and intracellular release of Ca++ from endoplasmic reticulum (ER) result in retardation. Objective To evaluate the skin permeability of lidocaine HCl loaded in nanoparticles made of carbomer calcified with calcium gluconate, while figuring out the physiological mechanism that regulates the Ca++ related skin barrier function. Methods Lidocaine hydrochloride was loaded in a nanoparticulate system based on calcified carbomer, fabricated by using a water-in-oil microemulsion as a precursor. In vitro release and percutaneous permeation testing were carried out to compare between calcified and non-calcified nanoparticles. In addition, comparison was also made between calcified nanoparticles using carbomer gels prepared at two pH values and at two different ratios of Ca++/carbomer. Results A unique structure of the calcified nanoparticles has been proposed, in which the carbomer nanoparticles are partially coated by gluconate ions through hydrogen bonding and partially through ionic interactions with calcium ions. Although the in vitro release data showed no difference between non-calcified and calcified carbomer nanoparticles, a calcium-related phenomenon of skin retardation has been revealed. Conclusions It has been proposed that stimulation of lamellar body secretion from granular cells and Ca++ release from ER, which is elicited by the calcium gluconate-coated nanoparticles, result in dermal retardation of lidocaine.Keywords
This publication has 27 references indexed in Scilit:
- Self-assembled nanoparticles of PLGA-conjugated glucosamine as a sustained transdermal drug delivery vehiclePolymer Journal, 2012
- Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfateBiomaterials, 2011
- The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKCα signalingThe FASEB Journal, 2010
- Percutaneous Penetration Modifiers and Formulation Effects: Thermal and Spectral AnalysesAAPS PharmSciTech, 2010
- Percutaneous penetration modifiers and formulation effectsInternational Journal of Pharmaceutics, 2010
- New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivoJournal of Controlled Release, 2004
- Iontophoresis and Sonophoresis Stimulate Epidermal Cytokine Expression at Energies That Do Not Provoke a Barrier Abnormality: Lamellar Body Secretion and Cytokine Expression Are Linked to Altered Epidermal Calcium LevelsJournal of Investigative Dermatology, 2003
- Origin of the Epidermal Calcium Gradient: Regulation by Barrier Status and Role of Active vs Passive MechanismsJournal of Investigative Dermatology, 2002
- Selective Obliteration of the Epidermal Calcium Gradient Leads to Enhanced Lamellar Body SecretionJournal of Investigative Dermatology, 1994
- Lamellar Body Secretory Response to Barrier DisruptionJournal of Investigative Dermatology, 1992